alexa Difficulties in Diagnostic Staging of Human African Trypanosomiasis | OMICS International | Abstract
E-ISSN: 2314-7326
P-ISSN: 2314-7334

Journal of Neuroinfectious Diseases
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Commentary

Difficulties in Diagnostic Staging of Human African Trypanosomiasis

Peter G. E. Kennedy*

Glasgow University Department of Neurology, College of Medical, Veterinary and Life Sciences, Ground Floor Neurology Block, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, Scotland, UK

*Corresponding Author:
Peter G. E. Kennedy
Glasgow University Department of Neurology
College of Medical, Veterinary and Life Sciences
Ground Floor Neurology Block, Institute of Neurological Sciences
Southern General Hospital, Glasgow G51 4TF, Scotland, UK
E-mail: [email protected]

Received Date: 16 June 2011; Accepted Date: 25 June 2011

Abstract

Human African trypanosomiasis (HAT), also known as sleeping sickness, continues to be a major hazard to human health in 36 countries in sub-Saharan Africa. One of the most important problems in disease management is the considerable difficulty in distinguishing the early (hemolymphatic) from the late (encephalitic) stage when the parasites have crossed the blood-brain barrier to enter the Central Nervous System (CNS). Treatment of the two stages is different with the highly toxic arsenical drug melarsoprol being the most commonly used therapy for CNS disease. Since melarsoprol kills 5% of treated patients, it is vital to develop reliable and agreed diagnostic staging markers for HAT. Although the current WHO staging criteria on the cerebrospinal fluid (CSF) are the most commonly used, there is still a lack of consensus as to their efficacy which has driven the current search for improved methods of HAT diagnostic staging which are considered here.

Keywords

Recommended Conferences
Share This Page
Top